Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Brachytherapy
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • This retrospective study examining TIPPB demonstrated excellent 5-year actuarial PSA-RFS rates. The assignment of risk profiles based on the results of multivariate analysis of prognostic factors identifies the expected PSA-RFS for patients undergoing TIPPB.

publication date

  • September 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10526671

Additional Document Info

start page

  • 301

end page

  • 6

volume

  • 5

number

  • 5